About this information
Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).
If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.
*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.
Download datasets of the summaries of completed access to information requests.
Current Search
Report Type
Organization
Disposition
Year
Month
Found 106 record(s)
Req # A-2021-03054
Copies of the preparation documents, meeting summaries and emails related to the weekly meetings between Douglas Clark and Mitchell Levine from January 1, 2020 to February 17, 2021.Organization: Patented Medicine Prices Review Board Canada
March 2021
Req # A-2021-03055
Copies of the preparation documents, meeting summaries and emails related to the July 8-12, 2019 meetings Douglas Clark attended.Organization: Patented Medicine Prices Review Board Canada
March 2021
Req # A-2021-03056
Copies of the preparation documents, meeting summaries and emails related to the July 15-19, 2019 meetings Douglas Clark attended.Organization: Patented Medicine Prices Review Board Canada
March 2021
Req # A-2021-03057
Copies of the preparation documents, meeting summaries and emails related to the December 2-6, 2019 meetings Douglas Clark attended.Organization: Patented Medicine Prices Review Board Canada
March 2021
Req # A-2021-03058
Copies of the preparation documents, meeting summaries and emails related to the December 9-13, 2019 meetings Douglas Clark attended.Organization: Patented Medicine Prices Review Board Canada
March 2021
Req # A-2021-03060
Copies of the preparation documents, meeting summaries and emails related to the March 2, 2020 meeting with Cystic Fibrosis Canada that Douglas Clark attended.Organization: Patented Medicine Prices Review Board Canada
March 2021
Req # A-2020-18437
Copies of all work plans, regulatory processes, consultation processes and departmental reports from June 1, 2020 to November 26, 2020. Include, but do not limit the scope of the request to, documents that detail the internal reporting and operational structure of the PMPRB, emails to/from the PMPRB executive, along with memos, briefing notes, fact sheets, and third party consultations provided to the PMPRB executive.Organization: Patented Medicine Prices Review Board Canada
March 2021
Req # A 2020_0001
Provide copies of any and all communication and information records produced between May 1, 2018, and March 6, 2020 regarding the potential of the federal governments selling equity in TMP, TMEP, and related government-owned assets, and any related considerations and analysis. This includes any and all letters or e-mails between employees and/or board members of CDIC (including employees and board members of the CDIC subsidiary Trans Mountain Corporation) and the Department of Finance or the office of the Minister of Finance. This also includes memos, briefing materials, background documents, research and analysis, powerpoint presentations, or any other written materials produced for internal consideration at CDIC or for review by officials at the Department of Finance or the office of the Minister of Finance.Organization: Canada Development Investment Corporation
February 2021
Req # A 2020_0008
The letter from Trans Mountain to CDEV referred to in the June 2019 minutes in screen shot [Letter from TMC to Minister of Finance and CDEV].Organization: Canada Development Investment Corporation
February 2021
Req # A-2020-14747
Copies of meeting minutes, presentations and speaking notes associated with rare disease drugs from May 1, 2020 to July 31, 2020.Organization: Patented Medicine Prices Review Board Canada
February 2021